November 18, 2025- Medtronic plc announced financial results for its second quarter (Q2) of fiscal year 2026 (FY26), which ended October 24, 2025. Medtronic reported Q2 worldwide revenue of $8.961 billion, an increase of 6.6% as reported and 5.5% on an organic basis. The organic revenue growth comparison excludes:
- Other revenue of $35 million in the current year and $37 million in the prior year;
- Revenue from the Dutch Obesity Clinic (NOK) divestiture of $5 million in the current year and $16 million in the prior year; and
- Foreign exchange benefit of $111 million on the remaining segments.
Continue Reading from Medtronic.